Expression of Elafin and CD200 as Immune Checkpoint Molecules Involved in Celiac Disease

Expression of Elafin and CD200 as Immune Checkpoint Molecules Involved in Celiac Disease

We comprehensively evaluated the expression of therapeutically targetable immune checkpoint molecules involved in celiac disease (CD). We have focused on the alteration of the CD200/CD200R pathway and Elafin expression in celiac disease and discussed their roles in regulating the immune response. Th...

Full description

Bibliographic Details
Main Authors:	Candelaria Ponce-de-León, Pedro Lorite, Miguel Ángel López-Casado, Pablo Mora, Teresa Palomeque, María Isabel Torres
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	International Journal of Molecular Sciences
Subjects:	CD200/CD200R Elafin celiac disease gluten peptides immune checkpoint
Online Access:	https://www.mdpi.com/1422-0067/25/2/852

Similar Items

Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200
by: Sun Young Moon, et al.
Published: (2023-10-01)

Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
by: Deborah Choe, et al.
Published: (2023-01-01)

CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy
by: Christopher Nip, et al.
Published: (2023-12-01)

Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer
by: Ioannis A. Vathiotis, et al.
Published: (2021-03-01)

CD200:CD200R Interactions and Their Importance in Immunoregulation
by: Katarzyna Kotwica-Mojzych, et al.
Published: (2021-02-01)

23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function
by: Jill Fenaux, et al.
Published: (2023-12-01)

CD200 and CD200R Expression on Peripheral Blood Lymphocytes and Serum CD200 Concentration as a New Marker of Endometriosis
by: Monika Abramiuk, et al.
Published: (2020-09-01)

High CD200 Expression on T CD4+ and T CD8+ Lymphocytes as a Non-Invasive Marker of Idiopathic Pulmonary Hypertension–Preliminary Study
by: Michał Tomaszewski, et al.
Published: (2021-03-01)

The CD200 Regulates Inflammation in Mice Independently of TNF-α Production
by: Katarzyna Tonecka, et al.
Published: (2021-05-01)

Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms
by: Wafaa Ahmed El- Neanaey, et al.
Published: (2020-01-01)

CD200-CD200R affects cisplatin and paclitaxel sensitivity by regulating cathepsin K-mediated p65 NF-κB signaling in cervical cancer
by: Junjun Mou, et al.
Published: (2023-08-01)

A new insight into viral proteins as Immunomodulatory therapeutic agents. KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory protein
by: Maryam Mousavinezhad-Moghaddam, et al.
Published: (2016-01-01)

Immune Checkpoint Pathway Expression in Lymphocyte Subpopulations in Patients with Common Variable Immunodeficiency and Chronic Lymphocytic Leukemia
by: Paulina Mertowska, et al.
Published: (2023-10-01)

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes, Cancer-Associated Fibroblasts, and CD200 in Pancreatic Cancer
by: Tyler MacNeil, et al.
Published: (2021-11-01)

Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris
by: Drahomira Holmannova, et al.
Published: (2020-08-01)

CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation
by: Seung-Phil Shin, et al.
Published: (2019-10-01)

The Role of CD200–CD200 Receptor in Human Blood and Lymphatic Endothelial Cells in the Regulation of Skin Tissue Inflammation
by: Dominic Rütsche, et al.
Published: (2022-03-01)

Brain endothelial CD200 signaling protects brain against ischemic damage
by: Afzal Misrani, et al.
Published: (2024-02-01)

CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia
by: Giovanni D’Arena, et al.
Published: (2021-08-01)

Utility of CD200 expression by flow cytometry in lymphoproliferative disorders and plasma cell dyscrasias
by: Pavuluri Divya, et al.
Published: (2023-01-01)

Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients
by: Mohamed Khalil, et al.
Published: (2023-01-01)

CD200 genotype is associated with clinical outcome of patients with multiple myeloma
by: Yolanda Gonzalez-Montes, et al.
Published: (2024-02-01)

Dynamic Monitoring of CD200 Mediated by Ascites-Derived Exosomes as a Predictor of Survival and Response to Front-Line Chemotherapeutics in Advanced High-Grade Serous Ovarian Cancer
by: Ying Ji, et al.
Published: (2023-10-01)

The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by: Mesude Falay, et al.
Published: (2018-05-01)

THE ROLE OF CD200/CD200R INTERACTIONS IN THE FORMATION OF IMMUNOLOGICAL TOLERANCE IN TRANSPLANTATION AND PREGNANCY
by: A. S. Arefieva, et al.
Published: (2018-12-01)

Maternal Immune Activation Sensitizes Male Offspring Rats to Lipopolysaccharide-Induced Microglial Deficits Involving the Dysfunction of CD200–CD200R and CX3CL1–CX3CR1 Systems
by: Katarzyna Chamera, et al.
Published: (2020-07-01)

PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer
by: Chun Wu, et al.
Published: (2023-06-01)

Evaluation of Leukocytes, B and T Lymphocytes, and expression of CD200 and CD23 on B lymphocytes in Patients with Atopic Dermatitis on Dupilumab Therapy—Pilot Study
by: Jarmila Čelakovská, et al.
Published: (2023-04-01)

Adherence to Gluten-Free Diet Restores Alpha Diversity in Celiac People but the Microbiome Composition Is Different to Healthy People
by: Orazio Palmieri, et al.
Published: (2022-06-01)

CD200 Change Is Involved in Neuronal Death in Gerbil Hippocampal CA1 Field Following Transient Forebrain Ischemia and Postischemic Treatment with Risperidone Displays Neuroprotection without CD200 Change
by: Tae-Kyeong Lee, et al.
Published: (2021-01-01)

CD200 in dentate gyrus improves depressive-like behaviors of mice through enhancing hippocampal neurogenesis via alleviation of microglia hyperactivation
by: Xi Chen, et al.
Published: (2023-06-01)

Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center
by: Mario Tiribelli, et al.
Published: (2021-06-01)

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer
by: Weiyu Lu, et al.
Published: (2023-01-01)

Engels@200: Friedrich Engels in the Age of Digital Capitalism. (Full Issue in One PDF)
by: Christian Fuchs
Published: (2020-11-01)

Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia
by: Lyons Anthony, et al.
Published: (2012-05-01)

The Presence of Psoriasis, Metabolic Syndrome and Their Combination Increases the Serum Levels of CRP and CD5L but Not sCD200R1 and sTLR2 in Participants
by: Drahomira Holmannova, et al.
Published: (2022-11-01)

High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma
by: I-Chen Wu, et al.
Published: (2021-06-01)

Global Prevalence and Associated Clinical Markers of Thrombocytopenia in People Living with HIV: Evidence from Meta-Analysis
by: Faisal K. Alkholifi, et al.
Published: (2022-10-01)

Challenges of Monitoring the Gluten-Free Diet Adherence in the Management and Follow-Up of Patients with Celiac Disease
by: Herbert Wieser, et al.
Published: (2021-06-01)

CD200 as a Potential New Player in Inflammation during Rotator Cuff Tendon Injury/Repair: An In Vitro Model
by: Raffaella Giancola, et al.
Published: (2022-12-01)